Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database

The aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in the period from 2000 to 2012 based on Surveillance, Epidemiology, and End Results (SEER) database. All 18 registries of the SEER database were used to select cases. We included women aged 30 years or older...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of gynecological cancer Vol. 26; no. 6; pp. 1098 - 1104
Main Authors Hosh, Mona, Antar, Sarah, Nazzal, Ahmed, Warda, Mahmoud, Gibreel, Ahmed, Refky, Basel
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 01.07.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in the period from 2000 to 2012 based on Surveillance, Epidemiology, and End Results (SEER) database. All 18 registries of the SEER database were used to select cases. We included women aged 30 years or older diagnosed with uterine sarcoma. Histological subtypes were defined as leiomyosarcoma, carcinosarcoma, stromal sarcoma, adenosarcoma, and sarcoma not otherwise specified according to the 2003 World Health Organization classification. Using SEER*Stat software version 8.1.2. We calculated the age-adjusted incidence rates, extent of disease at time of diagnosis, and survival rates with different treatment modalities for white, black, and other races. Univariate and multivariate Cox proportional hazards analysis were done to examine factors affecting survival. We identified 13,089 patients diagnosed with uterine sarcoma in the period from 2000 to 2012. The age-adjusted incidence rate for patients aged 50 years or older was more than that of younger patients (6.4/10 vs 1.5/10, P < 0.0001). Also, the age-adjusted incidence rate for black women was twice that of white women (7.3/10 vs 3.5/10, P < 0.0001). Carcinosarcoma was the most commonly diagnosed subtype followed by leiomyosarcoma. Women aged 50 years or older had worse survival than those younger than 50 years (hazard ratio, 1.78; 95% confidence interval, 1.64-1.92; P < 0.001). The overall survival of patients who had surgery with radiation was better than those who had surgery alone (hazard ratio, 0.89; 95% confidence interval, 0.83-0.95; P < 0.001). In women with localized disease, surgery was associated with better survival than surgery with radiation (66.4% vs 74.4%, P < 0.00001). Uterine sarcoma is an aggressive tumor that occurs more in old age and among women of black race. Poor survival was associated with old age, black race, and advanced disease stage. Radiotherapy in patients with localized stage does not improve the survival.
AbstractList ObjectiveThe aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in the period from 2000 to 2012 based on Surveillance, Epidemiology, and End Results (SEER) database.MethodsAll 18 registries of the SEER database were used to select cases. We included women aged 30 years or older diagnosed with uterine sarcoma. Histological subtypes were defined as leiomyosarcoma, carcinosarcoma, stromal sarcoma, adenosarcoma, and sarcoma not otherwise specified according to the 2003 World Health Organization classification. Using SEER*Stat software version 8.1.2. We calculated the age-adjusted incidence rates, extent of disease at time of diagnosis, and survival rates with different treatment modalities for white, black, and other races. Univariate and multivariate Cox proportional hazards analysis were done to examine factors affecting survival.ResultsWe identified 13,089 patients diagnosed with uterine sarcoma in the period from 2000 to 2012. The age-adjusted incidence rate for patients aged 50 years or older was more than that of younger patients (6.4/105 vs 1.5/105, P < 0.0001). Also, the age-adjusted incidence rate for black women was twice that of white women (7.3/105 vs 3.5/105, P < 0.0001). Carcinosarcoma was the most commonly diagnosed subtype followed by leiomyosarcoma. Women aged 50 years or older had worse survival than those younger than 50 years (hazard ratio, 1.78; 95% confidence interval, 1.64–1.92; P < 0.001). The overall survival of patients who had surgery with radiation was better than those who had surgery alone (hazard ratio, 0.89; 95% confidence interval, 0.83–0.95; P < 0.001). In women with localized disease, surgery was associated with better survival than surgery with radiation (66.4% vs 74.4%, P < 0.00001).ConclusionsUterine sarcoma is an aggressive tumor that occurs more in old age and among women of black race. Poor survival was associated with old age, black race, and advanced disease stage. Radiotherapy in patients with localized stage does not improve the survival.
The aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in the period from 2000 to 2012 based on Surveillance, Epidemiology, and End Results (SEER) database. All 18 registries of the SEER database were used to select cases. We included women aged 30 years or older diagnosed with uterine sarcoma. Histological subtypes were defined as leiomyosarcoma, carcinosarcoma, stromal sarcoma, adenosarcoma, and sarcoma not otherwise specified according to the 2003 World Health Organization classification. Using SEER*Stat software version 8.1.2. We calculated the age-adjusted incidence rates, extent of disease at time of diagnosis, and survival rates with different treatment modalities for white, black, and other races. Univariate and multivariate Cox proportional hazards analysis were done to examine factors affecting survival. We identified 13,089 patients diagnosed with uterine sarcoma in the period from 2000 to 2012. The age-adjusted incidence rate for patients aged 50 years or older was more than that of younger patients (6.4/10 vs 1.5/10, P < 0.0001). Also, the age-adjusted incidence rate for black women was twice that of white women (7.3/10 vs 3.5/10, P < 0.0001). Carcinosarcoma was the most commonly diagnosed subtype followed by leiomyosarcoma. Women aged 50 years or older had worse survival than those younger than 50 years (hazard ratio, 1.78; 95% confidence interval, 1.64-1.92; P < 0.001). The overall survival of patients who had surgery with radiation was better than those who had surgery alone (hazard ratio, 0.89; 95% confidence interval, 0.83-0.95; P < 0.001). In women with localized disease, surgery was associated with better survival than surgery with radiation (66.4% vs 74.4%, P < 0.00001). Uterine sarcoma is an aggressive tumor that occurs more in old age and among women of black race. Poor survival was associated with old age, black race, and advanced disease stage. Radiotherapy in patients with localized stage does not improve the survival.
Author Antar, Sarah
Warda, Mahmoud
Gibreel, Ahmed
Nazzal, Ahmed
Refky, Basel
Hosh, Mona
Author_xml – sequence: 1
  givenname: Mona
  surname: Hosh
  fullname: Hosh, Mona
  organization: Mansoura University Hospital; †Obstetrics and Gynecology Department, Mansoura University, Mansoura, Egypt, and ‡Oncology Center, Mansoura University, Mansoura, Egypt
– sequence: 2
  givenname: Sarah
  surname: Antar
  fullname: Antar, Sarah
– sequence: 3
  givenname: Ahmed
  surname: Nazzal
  fullname: Nazzal, Ahmed
– sequence: 4
  givenname: Mahmoud
  surname: Warda
  fullname: Warda, Mahmoud
– sequence: 5
  givenname: Ahmed
  surname: Gibreel
  fullname: Gibreel, Ahmed
– sequence: 6
  givenname: Basel
  surname: Refky
  fullname: Refky, Basel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27177280$$D View this record in MEDLINE/PubMed
BookMark eNpNkF9LwzAUxYNM3B_9BiIBX9eZmzZN4ttW5xwMBOfAt5I06ehom9m0wr69FSd44dx7H373wLljNKhdbRG6BTIDIvnDepXMyP_ilFygETDKAohCMeh3EolASPgYorH3h56RlMgrNKQcOKeCjNB-19qmqC3eqiZzlXrE81qVJ1947HIM4ZQIiRPlrceLvhvsarztmi9blKWqMzvFy2NhbFW40u1PU6xqg5e93qzvytbjJ9Uq3R9eo8tcld7enOcE7Z6X78lLsHldrZP5JsgiRkgAJiM5k4xyEeUaZGxyanIwlGnQOqdKaRoZHrJMSgVUE0EF1wC8j2_iDMIJuv_1PTbus7O-TQ-ua_pIPqWMSyLimP9Qd2eq05U16bEpKtWc0r-_hN9vEWUB
CitedBy_id crossref_primary_10_3389_fonc_2024_1354032
crossref_primary_10_1200_JCO_21_02050
crossref_primary_10_2147_CMAR_S267128
crossref_primary_10_3389_fsurg_2022_985654
crossref_primary_10_1038_s41379_022_01011_z
crossref_primary_10_1007_s13669_017_0197_z
crossref_primary_10_3390_clinpract11040103
crossref_primary_10_1186_s12905_022_02077_2
crossref_primary_10_1111_jog_13695
crossref_primary_10_1186_s12905_022_01739_5
crossref_primary_10_1007_s43032_021_00731_y
crossref_primary_10_1186_s12885_023_11000_3
crossref_primary_10_1007_s00261_021_03263_w
crossref_primary_10_3802_jgo_2020_31_e25
crossref_primary_10_1186_s12885_019_5879_7
crossref_primary_10_1007_s00432_023_04594_5
crossref_primary_10_1097_MD_0000000000025309
crossref_primary_10_1097_JCMA_0000000000000188
crossref_primary_10_1016_j_gore_2023_101308
crossref_primary_10_3389_fonc_2020_623818
crossref_primary_10_1080_14656566_2019_1571042
crossref_primary_10_1016_j_jogc_2018_02_005
crossref_primary_10_1136_ijgc_2020_001409
crossref_primary_10_1002_cam4_2044
crossref_primary_10_1097_GCO_0000000000000551
crossref_primary_10_1016_j_ygyno_2017_06_018
crossref_primary_10_2298_VSP230901063S
crossref_primary_10_5180_jsgoe_37_1_135
crossref_primary_10_1016_S1283_081X_19_42006_7
crossref_primary_10_21802_artm_2024_2_30_31
crossref_primary_10_1002_ccr3_1491
crossref_primary_10_1053_j_sult_2019_03_004
crossref_primary_10_1097_PGP_0000000000000918
crossref_primary_10_1200_JCO_19_00151
crossref_primary_10_3389_fonc_2020_608152
crossref_primary_10_1016_j_ygyno_2019_08_033
crossref_primary_10_1016_j_critrevonc_2017_12_009
crossref_primary_10_2214_AJR_24_31280
crossref_primary_10_1148_rg_220161
crossref_primary_10_1186_s13046_023_02687_0
crossref_primary_10_1016_j_ejso_2017_08_011
crossref_primary_10_1016_j_jogc_2017_03_090
crossref_primary_10_1007_s00404_023_07057_x
crossref_primary_10_1111_1471_0528_14579
crossref_primary_10_1245_s10434_023_13826_4
crossref_primary_10_5005_jp_journals_10006_2078
crossref_primary_10_1016_j_jogoh_2019_101631
crossref_primary_10_1016_j_ygyno_2018_10_034
crossref_primary_10_3390_jpm13060985
crossref_primary_10_1002_cac2_12067
crossref_primary_10_1097_IGC_0000000000000911
crossref_primary_10_1186_s13000_024_01517_x
crossref_primary_10_1002_uog_20270
crossref_primary_10_1002_cam4_4643
crossref_primary_10_1007_s00404_022_06515_2
crossref_primary_10_1016_j_crad_2020_11_115
crossref_primary_10_1097_MD_0000000000010268
crossref_primary_10_22159_ajpcr_2023_v16i2_46205
crossref_primary_10_1097_IGC_0000000000001289
crossref_primary_10_1016_j_ejogrb_2017_06_029
crossref_primary_10_1016_j_phymed_2018_12_029
crossref_primary_10_1097_AOG_0000000000004711
crossref_primary_10_1186_s12885_022_10129_x
crossref_primary_10_1111_his_14870
crossref_primary_10_3390_cimb45080390
crossref_primary_10_1007_s13224_021_01612_9
crossref_primary_10_21802_artm_2023_3_27_36
crossref_primary_10_1016_j_ygyno_2021_05_003
crossref_primary_10_1155_2020_8973262
crossref_primary_10_1016_j_ijscr_2022_107163
crossref_primary_10_1016_j_pathol_2017_11_086
crossref_primary_10_1053_j_semdp_2022_01_004
crossref_primary_10_1016_j_gore_2022_100980
crossref_primary_10_1097_MD_0000000000028220
crossref_primary_10_3892_mco_2021_2400
crossref_primary_10_5468_ogs_2019_62_2_103
crossref_primary_10_1080_01443615_2020_1803238
crossref_primary_10_1002_jcla_24502
crossref_primary_10_3390_cancers14061561
crossref_primary_10_28982_josam_878243
crossref_primary_10_1016_j_ejogrb_2017_10_030
crossref_primary_10_1148_radiol_211658
crossref_primary_10_1002_cam4_4665
crossref_primary_10_1186_s12955_022_01971_5
crossref_primary_10_1007_s13224_018_1141_5
crossref_primary_10_1371_journal_pone_0271526
crossref_primary_10_1007_s00292_022_01072_6
crossref_primary_10_1186_s12905_023_02161_1
crossref_primary_10_1007_s40944_018_0247_0
crossref_primary_10_1016_j_ajog_2018_11_1086
crossref_primary_10_1159_000494225
crossref_primary_10_1210_endrev_bnab039
crossref_primary_10_1177_15330338241245924
crossref_primary_10_1016_j_ijsu_2018_03_075
crossref_primary_10_1111_jog_14514
crossref_primary_10_1016_j_mcna_2022_10_010
crossref_primary_10_3390_cancers11101590
crossref_primary_10_1016_j_ygyno_2021_09_010
crossref_primary_10_1136_ijgc_2022_003383
crossref_primary_10_25259_SNI_621_2020
crossref_primary_10_3390_diagnostics14020160
crossref_primary_10_1136_bcr_2023_257228
crossref_primary_10_3390_cancers12082126
crossref_primary_10_1097_PPO_0000000000000678
crossref_primary_10_1007_s13691_021_00493_z
crossref_primary_10_1016_j_maturitas_2021_09_001
crossref_primary_10_1159_000494335
crossref_primary_10_1016_j_adro_2024_101500
crossref_primary_10_3390_cancers14081934
crossref_primary_10_1007_s12672_023_00613_6
crossref_primary_10_1097_PAS_0000000000002142
crossref_primary_10_1097_PAS_0000000000001055
ContentType Journal Article
Copyright 2016 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
Copyright_xml – notice: 2016 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PQEST
PQQKQ
PQUKI
PRINS
DOI 10.1097/IGC.0000000000000720
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList ProQuest One Academic Eastern Edition
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1525-1438
EndPage 1104
ExternalDocumentID 27177280
Genre Journal Article
GroupedDBID ---
.3N
.Z2
0R~
1OC
29J
31~
36B
4.4
53G
5GY
5VS
7X7
8-1
8FI
8FJ
AAKAS
AARTV
ABBUW
ABJNI
ABUWG
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACWDW
ACWRI
ACXNZ
ACXQS
ADZCM
AENEX
AFBPY
AFEBI
AFKRA
AFTRI
AFZJQ
AGINI
AHEFC
AIZYK
AJAOE
AJNYG
AJYBZ
ALMA_UNASSIGNED_HOLDINGS
AWKKM
BENPR
BFHJK
CAG
CCPQU
CGR
CO8
COF
CS3
CUY
CVF
CXRWF
DC6
DCZOG
E.X
EBS
ECM
EIF
EJD
EX3
F5P
FL-
FYUFA
FZ0
HAJ
HMCUK
HZI
HZ~
IHE
IN~
KD2
L-C
LH4
LW6
NPM
O9-
OCUKA
OHYEH
ORVUJ
OUVQU
OVD
OXXIT
P2P
RMJ
ROL
S4S
TEORI
UDS
UKHRP
V2I
W3M
W99
WOW
X3V
X3W
YUY
3V.
7XB
8FK
AAHLL
ALIPV
K9.
PQEST
PQQKQ
PQUKI
PRINS
ID FETCH-LOGICAL-c4500-1dc0f5952784fb196df2df1d25b1bbf2aab24d735c99a12b08287b117007d6c13
IEDL.DBID BENPR
ISSN 1048-891X
IngestDate Fri Sep 13 07:16:58 EDT 2024
Fri May 24 00:02:03 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4500-1dc0f5952784fb196df2df1d25b1bbf2aab24d735c99a12b08287b117007d6c13
PMID 27177280
PQID 2579086671
PQPubID 5161120
PageCount 7
ParticipantIDs proquest_journals_2579086671
pubmed_primary_27177280
PublicationCentury 2000
PublicationDate 2016-07-00
20160701
PublicationDateYYYYMMDD 2016-07-01
PublicationDate_xml – month: 07
  year: 2016
  text: 2016-07-00
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle International journal of gynecological cancer
PublicationTitleAlternate Int J Gynecol Cancer
PublicationYear 2016
Publisher BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group LTD
SSID ssj0009209
Score 2.5332344
Snippet The aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in the period from 2000 to 2012 based on Surveillance, Epidemiology,...
ObjectiveThe aim was to study the incidence and survival of patients with uterine sarcoma diagnosed in the period from 2000 to 2012 based on Surveillance,...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1098
SubjectTerms Adult
Age
Carcinosarcoma - epidemiology
Confidence intervals
Epidemiology
Female
Humans
Incidence
Leiomyosarcoma - epidemiology
Proportional Hazards Models
Radiation
Registries
Sarcoma
Sarcoma - epidemiology
Sarcoma, Endometrial Stromal - epidemiology
SEER Program
Surgery
Surveillance
United States - epidemiology
Uterine cancer
Uterine Neoplasms - epidemiology
Title Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database
URI https://www.ncbi.nlm.nih.gov/pubmed/27177280
https://www.proquest.com/docview/2579086671/abstract/
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFG_4SIwX47cokh480rB269Z5MYJDNIEQkIQb6cfqRTeEYeJ_b7uPcNIma9LDLv21fa997_1-ANwRRnXMhEA8cCnyNMaIcaaRMNbd05JqmtMXjyf-aOG9LumyBkZVLYxNq6zOxPygVqm0b-Q9s7RC4377Ae5xYV8BZNZ7WH8hqx9l46ylmEYdNAn2bMC22Y8m09megLdI9zC3D4ZYiJdVGV0Y9F6eBwWNYdUC4vztcOaGZ3gMjkqPET4WEJ-AWpycgoNxGRM_A--LLC_hg3OzZtNPfg8rohGYaojdrsNCODDGagv7plcwTeB8t_mOrd6QgbwLo71K7E8X8kTByHyzeLv7yLbwiWfc2rpzsBhGb4MRKuUTkPSo4yCspKNpSG1oUQuz05QmSmNFqMBCaMK5IJ4yEMkw5JiInPteWCUaJ1C-xO4FaCRpEl8B6GutHS4dFijmcR4KL3ZdLaVPMVOYyBZoV7O1KvfAdrVHrAUuixlcrQsKjRUxt0grjHX9_4834NA4KH6RHtsGjWyzi2-NE5CJDqgHy6BTomxGk-n4F54nsIE
link.rule.ids 315,786,790,12083,21416,27957,27958,31754,33779,43345,43840,74102,74659
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV27TsMwFLWgSMCCeFMo4IGxFrFjJw4LgtLSAmUAKnWL_IhZIClNisTfY-ehThAp2bL4XPse-16fA8AF4cwkXEokQp8hajBGXHCDpM3u1ChmWClfPH4OhhP6MGXT-sAtr9sqmzWxXKh1ptwZ-aUNrcjS7yDE17Mv5FyjXHW1ttBYBWvU96lr6Qun4VJ0t2rxsDsOjniEp83VuSi8HN33KunC5gmJ9zfJLJPNYBts1SwR3lSw7oCVJN0F6-O6Dr4H3idFeW0Pvto4zT7FFWzERWBmIPa7Ho9gzyaoHN7ar4ZZCl8X8-_EeQxZmLuwv3SG_elCkWrYt-9Lki8-ihzeiUK4_LYPJoP-W2-IassEpCjzPIS18gyLmCsnGmlnlzZEG6wJk1hKQ4SQhGoLi4oigYks9e6lc5_xQh0o7B-AVpqlyRGAgTHGE8rjoeZUiEjSxPeNUgHDXGOi2qDTjFZcx30eL1Fqg8NqBONZJZsRE7tzdGZYx___eA42hm_jp_hp9Px4AjYtQQmq9tgOaBXzRXJqSUAhz0qkfwHpSqxb
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV27TsMwFLWgSIgF8aZQwANjrdpOnDgsCEpLy0sIqNQt8iNmgaQ0KRJ_j52HOkEkZ_PiY_te-x6fA8A55cwkXEokQo8h3xCCuOAGSRvdfaOYYaV88eNTMJr4d1M2rflPeU2rbPbEcqPWmXJ35D07tSKbfgch6ZmaFvF8M7ycfSHnIOUqrbWdxipYs1ESOzeDcBouBXgruoc9fXDEIzJtntFFYW98269kDJsvpPjvhLMMPMMtsFlnjPCqgngbrCTpDlh_rGviu-B9UpRP-OCrnbPZp7iAjdAIzAwkXhfzCPZtsMrhtf1rmKXwdTH_TpzfkIW8CwdLl9ifLhSphgPbXpJ88VHk8EYUwsW6PTAZDt76I1TbJyDlM4wR0QobFjFXWjTSrjRtqDZEUyaJlIYKIamvLUQqigShstS-l86JBoc6UMTbB600S5NDAANjDBYK81BzX4hI-onnGaUCRrgmVLVBpxmtuF4DebxErA0OqhGMZ5WERkztKdIZYx393_EMrFuQ44fx0_0x2LC5SlAxZTugVcwXyYnNBwp5WgL9C99asIc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Uterine+Sarcoma%3A+Analysis+of+13%2C089+Cases+Based+on+Surveillance%2C+Epidemiology%2C+and+End+Results+Database&rft.jtitle=International+journal+of+gynecological+cancer&rft.au=Hosh%2C+Mona&rft.au=Antar%2C+Sarah&rft.au=Nazzal%2C+Ahmed&rft.au=Warda%2C+Mahmoud&rft.date=2016-07-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=1048-891X&rft.eissn=1525-1438&rft.volume=26&rft.issue=6&rft.spage=1098&rft.epage=1104&rft_id=info:doi/10.1097%2FIGC.0000000000000720&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1048-891X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1048-891X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1048-891X&client=summon